ChemicalBook

2-[3,5-Dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-2,3,4,5-tetrahydro-3,5-dioxo-1,2,4-triazine-6-carboxamide

 структура
2542029-02-5
CAS №
2542029-02-5
английское имя:
2-[3,5-Dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-2,3,4,5-tetrahydro-3,5-dioxo-1,2,4-triazine-6-carboxamide
Синонимы:
resmetirom Impurity 30; 2-(3,5-dichloro-4-((5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yl)oxy)phenyl)-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazine-6-carboxamide;2-[3,5-Dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-2,3,4,5-tetrahydro-3,5-dioxo-1,2,4-triazine-6-carboxamide
CBNumber:
CB313797617
Формула:
C17H14Cl2N6O5
молекулярный вес:
453.24
MOL File:
2542029-02-5.mol

2-[3,5-Dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-2,3,4,5-tetrahydro-3,5-dioxo-1,2,4-triazine-6-carboxamide атрибут

плотность: 1.74±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)
пка: 4.99±0.40(Predicted)

Заявления о рисках и безопасности

2-[3,5-Dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-2,3,4,5-tetrahydro-3,5-dioxo-1,2,4-triazine-6-carboxamide химические свойства, назначение, производство

2-[3,5-Dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-2,3,4,5-tetrahydro-3,5-dioxo-1,2,4-triazine-6-carboxamide препаратная продукция и сырье

сырьё

препарат


2-[3,5-Dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-2,3,4,5-tetrahydro-3,5-dioxo-1,2,4-triazine-6-carboxamide поставщик

Global( 5)Suppliers
поставщик телефон страна номенклатура продукции благоприятные условия
Shandong Chengchuang Blue Sea Pharmaceutical Technology Co., Ltd. 0531-58897130 15508676053
China 1932 58
Hubei Moco Chemical Co., Ltd. 18627753421
China 10987 58
ShenZhen H&D Pharmaceutical Technology Co., LTD 13986652530
China 4140 58
Jinan Jiuli Biotechnology Co. , Ltd. 15865264761
China 2860 58
Jurong Coupling Biotechnology Co., Ltd. 13656108824
China 416 58
Copyright 2017 © ChemicalBook. All rights reserved